DR. VAN COTTHEM ILSE ANESTHESIE: what changed
What changed
DR. VAN COTTHEM ILSE ANESTHESIE
NACE 86.220, Specialist medical practice
filed annual accounts (NBB)
Net result for the year
€117,875
2024 · €84,376+€33,499
Equity
€683,910
2024 · €585,707+€98,203
Cash
€1.1m
2024 · €967,821+€125,261
Balance sheet total
€1.1m
2024 · €997,942+€145,466
Largest movements
Assets
- Cash +€125,261
up €125,261 (+12.9%), from €967,821 to €1.1m
mainly Net result for the year (+€117,875) and Other debts (+€38,181)
- Receivables within one year +€28,489
new in 2025: €28,489
- Tangible fixed assets -€12,813
down €12,813 (-57.4%), from €22,335 to €9,522
Equity and liabilities
- Reserves +€98,203
up €98,203 (+30.4%), from €323,307 to €421,510
- Other debts +€38,181
up €38,181 (+25.3%), from €150,983 to €189,164
Income statement
- Gross operating margin +€47,998
up €47,998 (+31.8%), from €150,790 to €198,788
- Taxes +€15,932
up €15,932 (+47.4%), from €33,614 to €49,546
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€84,376
Gross operating margin
+€47,998
Depreciation
+€1
Financial income
+€588
Financial charges
+€844
Taxes
-€15,932
Result 2025
€117,875
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€144,933
Investment
€0
Financing
-€19,672
Cash 2024
€967,821
From operations (derived)
+€144,933
Net result for the year
+€117,875
Depreciation
+€12,813
Receivables within one year
-€28,489
Deferred charges and accrued income
-€4,529
Trade debts
+€602
Tax, wage and social debts
+€8,480
Other debts
+€38,181
Financing
-€19,672
Contributions, distributions and other
-€19,672
Cash 2025
€1.1m
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €997,942 | €1,143,408 | +€145,466 | +14.6% |
| Fixed assets | 21/28 | €22,335 | €9,522 | -€12,813 | -57.4% |
| Tangible fixed assets | 22/27 | €22,335 | €9,522 | -€12,813 | -57.4% |
| Furniture and vehicles | 24 | €22,335 | €9,522 | -€12,813 | -57.4% |
| Current assets | 29/58 | €975,607 | €1,133,886 | +€158,279 | +16.2% |
| Amounts receivable within one year | 40/41 | - | €28,489 | +€28,489 | |
| Trade receivables | 40 | - | €28,489 | +€28,489 | |
| Cash at bank and in hand | 54/58 | €967,821 | €1,093,082 | +€125,261 | +12.9% |
| Deferred charges and accrued income | 490/1 | €7,786 | €12,315 | +€4,529 | +58.2% |
| Total equity and liabilities | 10/49 | €997,942 | €1,143,408 | +€145,466 | +14.6% |
| Equity | 10/15 | €585,707 | €683,910 | +€98,203 | +16.8% |
| Contributions | 10/11 | €262,400 | €262,400 | = | 0.0% |
| Reserves | 13 | €323,307 | €421,510 | +€98,203 | +30.4% |
| Distributable reserves | 133 | €323,307 | €421,510 | +€98,203 | +30.4% |
| Amounts payable | 17/49 | €412,235 | €459,498 | +€47,263 | +11.5% |
| Amounts payable after more than one year | 17 | €250,000 | €250,000 | = | 0.0% |
| Trade debts | 175 | €250,000 | - | -€250,000 | |
| Other amounts payable | 178/9 | - | €250,000 | +€250,000 | |
| Amounts payable within one year | 42/48 | €162,235 | €209,498 | +€47,263 | +29.1% |
| Trade debts | 44 | €4,788 | €5,390 | +€602 | +12.6% |
| Suppliers | 440/4 | €4,788 | €5,390 | +€602 | +12.6% |
| Taxes, remuneration and social security | 45 | €6,464 | €14,944 | +€8,480 | +131% |
| Taxes | 450/3 | €6,464 | €14,944 | +€8,480 | +131% |
| Other amounts payable | 47/48 | €150,983 | €189,164 | +€38,181 | +25.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,814 | €12,813 | -€1 | 0.0% |
| Gross operating margin | 9900 | €150,790 | €198,788 | +€47,998 | +31.8% |
| Operating profit (loss) | 9901 | €137,976 | €185,975 | +€47,999 | +34.8% |
| Financial income | 75/76B | €237 | €825 | +€588 | +248% |
| Recurring financial income | 75 | €237 | €825 | +€588 | +248% |
| Financial charges | 65/66B | €20,223 | €19,379 | -€844 | -4.2% |
| Recurring financial charges | 65 | €20,223 | €19,379 | -€844 | -4.2% |
| Profit (loss) for the period before taxes | 9903 | €117,990 | €167,421 | +€49,431 | +41.9% |
| Income taxes | 67/77 | €33,614 | €49,546 | +€15,932 | +47.4% |
| Profit (loss) for the period | 9904 | €84,376 | €117,875 | +€33,499 | +39.7% |
| Profit (loss) for the period to be appropriated | 9905 | €84,376 | €117,875 | +€33,499 | +39.7% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.